Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 24;15(7):787.
doi: 10.3390/ph15070787.

Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing

Jong H Kim  1 , Luisa W Cheng  1 , Kirkwood M Land  2
Affiliations
Editorial

Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing

Jong H Kim et al. Pharmaceuticals (Basel). .

Abstract

This Special Issue of Pharmaceuticals describes recent advances accomplished in the field of antifungal development, especially the discovery of new drugs and drug repurposing [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Roemer T., Krysan D.J. Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches. Cold Spring Harb. Perspect. Med. 2014;4:a019703. doi: 10.1101/cshperspect.a019703. - DOI - PMC - PubMed
    1. Houšť J., Spížek J., Havlíček V. Antifungal Drugs. Metabolites. 2020;10:106. doi: 10.3390/metabo10030106. - DOI - PMC - PubMed
    1. Nami S., Aghebati-Maleki A., Morovati H., Aghebati-Maleki L. Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases. Biomed. Pharmacother. 2019;110:857–868. doi: 10.1016/j.biopha.2018.12.009. - DOI - PubMed
    1. Nett J.E., Andes D.R. Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infect. Dis. Clin. N. Am. 2016;30:51–83. doi: 10.1016/j.idc.2015.10.012. - DOI - PubMed
    1. Rajendran R., Mowat E., Jones B., Williams C., Ramage G. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. Int. J. Antimicrob. Agents. 2015;46:342–345. doi: 10.1016/j.ijantimicag.2015.03.006. - DOI - PubMed

Publication types

LinkOut - more resources